BMS
BMS is a US-approved specialty pharmaceutical manufacturer. Reserve Meds supports cross-border NPP access to BMS products.
Drugs from BMS supported via NPP
| Brand | Generic | Category | Indication |
|---|---|---|---|
| Breyanzi | lisocabtagene maraleucel | Oncology (LBCL/CLL) | DLBCL, CLL/SLL, FL, MCL |
| Augtyro | repotrectinib | Oncology (ROS1/NTRK) | ROS1+ NSCLC; NTRK+ solid tumors |
| Camzyos | mavacamten | Cardiology (HCM) | Obstructive HCM |
How NPP access to BMS products works
Reserve Meds sources BMS products from DSCSA-compliant US specialty wholesalers, not from parallel-import channels. All supply is US-FDA-provenance.
Not affiliated with BMS
Reserve Meds is an independent NPP operator. We are not a subsidiary, affiliate, or authorised distributor of BMS.